The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501).
 
Yoshiaki Iwasaki
No Relationships to Disclose
 
Masanori Terashima
Honoraria - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)
 
Junki Mizusawa
No Relationships to Disclose
 
Hiroshi Katayama
Honoraria - Johnson & Johnson
 
Kenichi Nakamura
Honoraria - Eisai; Merck Serono; Nihonkayaku; Taiho Pharmaceutical
 
Hitoshi Katai
Honoraria - Chugai Pharma; Covidien/Medtronic; Lilly Japan; Taiho Pharmaceutical
 
Takaki Yoshikawa
Honoraria - Abbott Nutrition; Ajinomoto; Chugai Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; Medtronic; Nihonkayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Chugai Pharma; MSD Oncology; Novartis
Research Funding - Chugai Pharma; Novartis; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Yuichi Ito
No Relationships to Disclose
 
Masahide Kaji
No Relationships to Disclose
 
Yutaka Kimura
No Relationships to Disclose
 
Motohiro Hirao
No Relationships to Disclose
 
Makoto Yamada
No Relationships to Disclose
 
Akira Kurita
No Relationships to Disclose
 
Masakazu Takagi
No Relationships to Disclose
 
Masahiro Gotoh
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma; Kyowa Hakko Kirin; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Taiho Pharmaceutical
 
Akinori Takagane
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Naoki Hirabayashi
No Relationships to Disclose
 
Takeshi Sano
Speakers' Bureau - Chugai Pharma; Johnson & Johnson; Lilly Japan; Medtronic; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Mitsuru Sasako
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo